Paul Geyer, Director at TIMIA Capital, holds 2.64M shares in TIMIA Capital (Ticker: TSE:MONT), holds 340.35K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX), holds 351.46K shares in Neovasc (Ticker: NVCN). Most recently, Paul Geyer Bought ― shares of TIMIA Capital on Mar 08, 2024 for an estimated value of 21.25K.